JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Unveiling mechanisms of lung aging in COPD: A promising target for therapeutics development

  • 0National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.
Chinese Medical Journal Pulmonary and Critical Care Medicine +

|

October 15, 2024

|

October 15, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) is linked to accelerated lung aging. Targeting aging mechanisms may offer new COPD treatments and address other age-related diseases.

Area Of Science

  • Pulmonary Medicine
  • Gerontology
  • Cellular Biology

Background

  • Chronic obstructive pulmonary disease (COPD) is a leading cause of death with no cure.
  • COPD prevalence increases with age, suggesting a link to accelerated lung aging.
  • Lung aging involves molecular and cellular changes impacting lung structure, function, and immunity.

Purpose Of The Study

  • To review recent advancements in understanding aging mechanisms.
  • To explore the role of accelerated lung aging in COPD pathophysiology and comorbidities.
  • To identify potential therapeutic targets within aging pathways for COPD and other age-related diseases.

Main Methods

  • Literature review of aging mechanisms and COPD.
  • Analysis of cellular senescence and its role in lung aging.
  • Examination of the senescence-associated secretory phenotype (SASP) in COPD.

Main Results

  • Accelerated lung aging in COPD involves oxidative stress, inflammation, and cellular senescence.
  • Senescent cells, characterized by specific cell cycle regulators (p21, p16, p53), contribute to lung disease.
  • The SASP produced by senescent cells promotes inflammation and tissue remodeling.

Conclusions

  • Understanding accelerated lung aging is crucial for COPD pathogenesis.
  • Targeting aging mechanisms, including cellular senescence and SASP, may lead to novel COPD therapeutics.
  • Therapies developed for COPD could potentially benefit other age-related conditions.

Keywords:

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology 01:20

2.7K

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...

COPD: Pathogenesis and Clinical Features 01:20

239

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-I: Introduction 01:20

2.8K

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Management Using Bronchodilators and Corticosteroids 01:26

184

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-V: Management 01:29

2.5K

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Primary Step: The most critical intervention for all COPD patients who smoke.
Benefits: Slows disease...

Chronic Obstructive Pulmonary Disease 01:22

1.2K

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...